Background: Few exercise trials in cancer patients have reported longer-term follow-up.
Here, we report a 6-month follow-up of exercise behavior and patient-rated outcomes from …

This study aimed to determine the feasibility and potential efficacy of a 12-wk aerobic
exercise intervention to mitigate cardiotoxicity in those with breast and hematological cancer …

Breast cancer is the most common malignancy affecting women and the second leading
cause of cancer death in women in the United States [1]. Due to improvements in detection …

Background To measure changes in four common chemotherapy related side-effects (low
energy, stress, nausea and pain) immediately after a single exercise session within the first …

While performing aerobic exercise during chemotherapy has been proven feasible and safe,
the efficacy of aerobic training on cardiorespiratory fitness (CRF) in women with breast …

Background Cardiotoxicity from chemotherapy is a serious risk to the quality of survival of
breast cancer survivors (BCS), and aerobic combined with resistance exercise (CE) has the …

Simple Summary The present study aimed to assess and compare the effects of receiving
CAF (cyclophosphamide/doxorubicin/fluorouracil) and AC-T (doxorubicin …

Introduction: There is growing evidence that aerobic exercise mitigates cancer therapy-
related side effects and improves cardiorespiratory fitness (CRF). However, to the best of our …

Cancer and its treatments affect cardiovascular (CV) health, including an increased risk of
CV death, decreased cardiorespiratory fitness (CRF), and cardiac dysfunction. Moreover …

Purpose Cardiovascular disease (CVD) is a leading cause of death among women with
nonmetastatic breast cancer. Whether exercise is associated with reductions in CVD risk in …